Corcept Therapeutics Files 8-K on Shareholder Votes & Financials
Ticker: CORT · Form: 8-K · Filed: Jun 16, 2025 · CIK: 1088856
Sentiment: neutral
Topics: corporate-governance, financial-reporting
TL;DR
CORCEPT filed an 8-K on 6/16/25 covering shareholder votes and financials as of 6/10/25.
AI Summary
Corcept Therapeutics Incorporated filed an 8-K on June 16, 2025, reporting on matters submitted to a vote of security holders and financial statements as of June 10, 2025. The filing details the company's corporate structure, including its state of incorporation (Delaware) and fiscal year end (December 31).
Why It Matters
This filing provides essential updates on corporate governance and financial reporting for Corcept Therapeutics, informing investors about key company actions and status.
Risk Assessment
Risk Level: low — This is a routine corporate filing (8-K) that primarily reports on administrative and financial matters without disclosing new material events or significant financial performance changes.
Key Numbers
- 000-50679 — SEC File Number (Identifies the company's registration with the SEC)
- 77-0487658 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- Corcept Therapeutics Incorporated (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- June 10, 2025 (date) — Earliest event date reported
- June 16, 2025 (date) — Filing date
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates that 'Submission of Matters to a Vote of Security Holders' is an item reported, but the specific details of these matters are not provided in the excerpt.
What is the principal executive office address for Corcept Therapeutics?
The principal executive offices are located at 101 Redwood Shores Parkway, Redwood City, CA 94065.
When is Corcept Therapeutics' fiscal year end?
Corcept Therapeutics' fiscal year ends on December 31.
What is the SIC code for Corcept Therapeutics?
The Standard Industrial Classification (SIC) code for Corcept Therapeutics is 2834, which corresponds to Pharmaceutical Preparations.
What is the filing date of this 8-K report?
This 8-K report was filed as of June 16, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 16, 2025 regarding CORCEPT THERAPEUTICS INC (CORT).